Ausgabe 2/2003
Inhalt (22 Artikel)
Id-1 is not expressed in the luminal epithelial cells of mammary glands
Norihisa Uehara, Yu-Chien Chou, Jose J Galvez, Paola de-Candia, Robert D Cardiff, Robert Benezra, Gopalan Shyamala
Articles selected from Faculty of 1000 in October 2002
Waist–hip ratio and breast cancer risk in urbanized Nigerian women
Clement A Adebamowo, Temidayo O Ogundiran, Adeniyi A Adenipekun, Rasheed A Oyesegun, Oladapo B Campbell, Effiong E Akang, Charles N Rotimi, Olunfunmilayo I Olopade
C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
Claus M Schlotter, Ulf Vogt, Ulrich Bosse, Berthold Mersch, Katja Waβmann
Akt kinases in breast cancer and the results of adjuvant therapy
Olle Stål, Gizeh Pérez-Tenorio, Linda Åkerberg, Birgit Olsson, Bo Nordenskjöld, Lambert Skoog, Lars Erik Rutqvist
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors
Christine B Ambrosone, Kirsten B Moysich, Helena Furberg, Jo L Freudenheim, Elise D Bowman, Sabrina Ahmed, Saxon Graham, John E Vena, Peter G Shields
A candidate metastasis-associated DNA marker for ductal mammary carcinoma
Patnala Mohan R Achary, Hui Zhao, Zuoheng Fan, Swarna Gogineni, Venkat R Pulijaal, Lawrence Herbst, Panna S Mahadevia, Joan G Jones, Harold P Klinger, Bhadrasain Vikram
The prolyl isomerase Pin1 in breast development and cancer
Gerburg Wulf, Akihide Ryo, Yih-Cherng Liou, Kun Ping Lu
Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis
Joanne L Yu, Janusz W Rak
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
Carlos L Arteaga
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on preclinical and translational research
Julia E Head, Alistair Ring
25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research
Alistair Ring, Julia Head
Breast cancer cell lines: friend or foe?
Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs
Host microenvironment in breast cancer development: Epithelial–mesenchymal transition in breast cancer development
Anne Vincent-Salomon, Jean Paul Thiery
Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1
Mina J Bissell, David Bilder
New insights into the biological function of BRCA2 from its structural interactions
Alison Waterworth